Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 1/20 | 0.45 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.45 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.45 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | SCN4A | P35499 | 1/20 | 0.44 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 1/20 | 0.39 |
| ▸ | MPL | P40238 | 2/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | FBP1 | P09467 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL696472 | 0.85 | KIF11 (0.44) | PTPRCPTPN6PTPN11PTPN22DYRK1A | |
| SCHEMBL826881 | 0.83 | PTPRC (0.62) | PTPRCPTPN6PTPN11PTPN22EPHX2 | |
| SCHEMBL29379298 | 0.83 | PTPRC (0.62) | PTPRCPTPN6PTPN11PTPN22EPHX2 | |
| SCHEMBL15590663 | 0.81 | PTPRC (0.44) | PTPRCPTPN6PTPN11PTPN22MEN1 | |
| SCHEMBL3799533 | 0.79 | ALDH1A1 (0.39) | PTPRCPTPN6PTPN11PTPN22CYP2A6 | |
| SCHEMBL15582380 | 0.78 | PTPRC (0.42) | PTPRCPTPN6PTPN11PTPN22 | |
| SCHEMBL21025987 | 0.76 | PTPRC (0.36) | PTPRCPTPN6PTPN11PTPN22CYP2A6 | |
| SCHEMBL25572192 | 0.76 | PTPRC (0.38) | PTPRCPTPN6PTPN11PTPN22 | |
| SCHEMBL25571571 | 0.73 | PTPRC (0.35) | PTPRCPTPN6PTPN11PTPN22 | |
| SCHEMBL25572189 | 0.73 | PTPRC (0.35) | PTPRCPTPN6PTPN11PTPN22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116018039-B | Tin-based perovskite material, and preparation method and application thereof | 南方科技大学 | 2025-08-19 | — | — | CN | disclosed |
| US-20220213039-A1 | PYRIDINIUM SALTS AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2022-07-07 | — | — | US | disclosed |
| CN-105263926-B | Benzothienyl compounds | 安斯泰来制药株式会社 | 2018-05-11 | — | — | CN | disclosed |
| EP-3006443-B1 | BENZOTHIOPHENE COMPOUND | ASTELLAS PHARMA INC (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-20170369486-A1 | GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTONIC ACETYLCHOLINE RECEPTORS | AXOVANT SCIENCES GMBH (CH) | 2017-12-28 | — | — | US | disclosed |
| CN-105503822-B | The preparation method of trifluoromethyl benzothiophene derivative | 温州大学 | 2017-11-24 | — | — | CN | disclosed |
| CN-104672220-B | The activator of peroxisome proliferator-activated receptor | 日本化学医药株式会社 | 2017-09-22 | — | — | CN | disclosed |
| CN-107074857-A | Method for preparing crystallization organic semiconducting materials | 巴斯夫欧洲公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-107004768-A | Organic semiconductor composition containing a liquid medium | 巴斯夫欧洲公司 | 2017-08-01 | — | — | CN | disclosed |
| US-9399038-B2 | Benzothiophene compound | ASTELLAS PHARMA INC. (JP) | 2016-07-26 | — | — | US | disclosed |
| US-20040220173-A1 | Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor | AVENTIS PHARMACEUTICAL INC. (US) | 2004-11-04 | — | — | US | disclosed |
| EP-1392676-A2 | HETEROCYCLIC UREA DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS | Aventis Pharmaceuticals, Inc. (US) | 2004-03-03 | — | — | EP | disclosed |
| US-20040030137-A1 | Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-02-12 | — | — | US | disclosed |
| US-20030229066-A1 | Novel heterocyclic urea derivatives and their use as dopamine D3 receptor ligands | AVENTIS PHARMACEUTICALS INC. | 2003-12-11 | — | — | US | disclosed |
| EP-1361875-A2 | NOVEL HETEROCYCLIC AMIDE DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS | Aventis Pharmaceuticals Inc. (US) | 2003-11-19 | — | — | EP | disclosed |
| EP-1362039-A1 | HETEROCYCLIC SUBSTITUTED CARBONYL DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS | Aventis Pharmaceuticals, Inc. (US) | 2003-11-19 | — | — | EP | disclosed |
| WO-2002066468-A2 | HETEROCYCLIC UREA DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS | AVENTIS PHARMACEUTICALS INC. (US) | 2002-08-29 | — | — | WO | disclosed |
| WO-2002066469-A2 | NOVEL HETEROCYCLIC AMIDE DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS | AVENTIS PHARMACEUTICALS INC. (US) | 2002-08-29 | — | — | WO | disclosed |
| WO-2002066446-A1 | HETEROCYCLIC SUBSTITUTED CARBONYL DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS | AVENTIS PHARMACEUTICALS INC. (US) | 2002-08-29 | — | — | WO | disclosed |
| US-5304657-A | Insecticides | ISHIHARA SANGYO KAISHA LTD. (JP) | 1994-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040030137-A1 | Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands | DRD3, DRD2, DRD1 | PTPRC 694/4885PTPN6 2453/4885PTPN11 2567/4885 |
| US-20030229066-A1 | Novel heterocyclic urea derivatives and their use as dopamine D3 receptor ligands | DRD3, DRD2, DRD1 | PTPRC 827/4885PTPN6 2603/4885PTPN11 2767/4885 |
| US-20040220173-A1 | Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor | DRD3, DRD2, DRD1 | PTPRC 368/4885PTPN6 2178/4885PTPN11 2305/4885 |
| US-20170369486-A1 | GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTONIC ACETYLCHOLINE RECEPTORS | CHRNA7, CHRNA6, CHRNA5 | PTPRC 4307/4885PTPN6 3882/4885PTPN11 3855/4885 |
| US-20220213039-A1 | PYRIDINIUM SALTS AND PEST CONTROL AGENT | ZYX, PNPO, PRDX1 | PTPRC 808/4885PTPN6 64/4885PTPN11 212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.